IperionX Limited (NASDAQ:IPX - Free Report) - B. Riley issued their FY2025 EPS estimates for shares of IperionX in a research note issued on Thursday, October 10th. B. Riley analyst L. Pipes expects that the company will earn ($0.08) per share for the year. B. Riley has a "Buy" rating and a $30.00 price objective on the stock. B. Riley also issued estimates for IperionX's FY2026 earnings at $0.05 EPS and FY2027 earnings at $0.24 EPS.
Separately, ThinkEquity raised shares of IperionX to a "strong-buy" rating in a research note on Tuesday, June 25th.
Check Out Our Latest Stock Analysis on IPX
Shares of IPX opened at $24.76 on Monday. IperionX has a 12-month low of $7.20 and a 12-month high of $25.00. The firm has a 50-day moving average price of $18.28 and a 200 day moving average price of $15.86. The company has a debt-to-equity ratio of 0.02, a current ratio of 13.62 and a quick ratio of 13.61.
An institutional investor recently bought a new position in IperionX stock. EntryPoint Capital LLC bought a new position in shares of IperionX Limited (NASDAQ:IPX - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,220 shares of the company's stock, valued at approximately $33,000. Institutional investors own 2.76% of the company's stock.
IperionX's mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D printing. IperionX's breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, 100% recyclable, have low carbon intensity and to do so at product qualities that meet or exceed current industry standards.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider IperionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.
While IperionX currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.